Impact Of Conditioning Regimen, Donor Source, and DIPSS Score On Outcome Of Allogeneic Hematopoietic Stem Cell Transplantation For Myelofibrosis

被引：1
|
作者：
Kroeger, Nicolaus
Ditschkowski, Markus
Scott, Bart L.
Zabelina, Tatjana
Alchalby, Haefaa
Beelen, Dietrich
Deeg, H. Joachim
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.712.712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
712
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis
    Keyzner, Alla
    Han, Sarah
    Shapiro, Samantha
    Moshier, Erin
    Schorr, Emily
    Petersen, Bruce
    Najfeld, Vesna
    Kremyanskaya, Marina
    Isola, Luis
    Hoffman, Ronald
    Mascarenhas, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2180 - 2186
  • [32] Impact of Donor Age on Outcome after Allogeneic Hematopoietic Cell Transplantation
    Rezvani, Andrew R.
    Storer, Barry E.
    Guthrie, Katherine A.
    Schoch, H. Gary
    Maloney, David G.
    Sandmaier, Brenda M.
    Storb, Rainer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (01) : 105 - 112
  • [33] Allogeneic stem cell transplantation in patients with chronic myelomonocytic leukaemia: the impact of WHO classification and of the conditioning regimen on the transplantation outcome
    Symeonidis, A.
    van Biezen, A.
    Mufti, G.
    Finke, J.
    Beelen, D.
    Bornhauser, M.
    Greinix, H.
    Jouet, J. P.
    Volin, L.
    Schwerdtfeger, R.
    de Witte, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S241 - S241
  • [34] Is antilymphocyte globulin useful in conditioning regimen of unrelated donor hematopoietic stem cell transplantation?
    Esperou, H
    Appert, ML
    Agha, IY
    Milpied, N
    Ifrah, N
    Kuentz, M
    Chir, Z
    Raffoux, C
    BLOOD, 2005, 106 (11) : 584A - 585A
  • [35] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    M Ditschkowski
    D W Beelen
    R Trenschel
    M Koldehoff
    A H Elmaagacli
    Bone Marrow Transplantation, 2004, 34 : 807 - 813
  • [36] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    Ditschkowski, M
    Beelen, DW
    Trenschel, R
    Koldehoff, M
    Elmaagacli, AH
    BONE MARROW TRANSPLANTATION, 2004, 34 (09) : 807 - 813
  • [37] Safety and outcome of allogeneic stem cell transplantation in myelofibrosis
    Markiewicz, Miroslaw
    Mietla, Monika Dzierzak
    Wieczorkiewicz, Agata
    Mizia, Sylwia
    Helbig, Grzegorz
    Kopera, Malgorzata
    Bialas, Krzysztof
    Rybicka, Malwina
    Matyja, Mariusz
    Koclega, Anna
    Sedlak, Lech
    Oleksy, Tomasz
    Raman, Sundar
    Kyrcz-Krzemien, Slawomira
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (03) : 222 - 228
  • [38] Thiotepa-busulfan-fludarbine as Conditioning Regimen for Patients with Myelofibrosis undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 307 - 308
  • [39] Hematopoietic chimerism and clinical outcome after allogeneic peripheral blood stem cell transplantation with MMC conditioning regimen.
    Liu, T
    Jia, YQ
    Lei, S
    Zhou, HY
    Li, YB
    Deng, CG
    BLOOD, 1999, 94 (10) : 358B - 358B
  • [40] RISK SCORE PREDICTS OUTCOME OF SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Rezvani, K.
    Marin, D.
    Goldman, J. M.
    Kanfer, E.
    MacDonald, D.
    Dazzi, F.
    Milojkovic, D.
    Rahemtulla, A.
    Sargeant, J.
    Apperley, J.
    Szydlo, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S155 - S155
12345